PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
42 hedge funds and large institutions have $328M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 18 closing their positions.
Holders
42
Holders Change
+4
Holders Change %
+10.53%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
22
Increased
6
Reduced
8
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$41.3M |
2 |
2
BlackRock
New York
|
$5.46M |
3 |
3
Bank of America
Charlotte,
North Carolina
|
$2.95M |
4 |
4
Bank of New York Mellon
New York
|
$2.58M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.88M |